Table 1.
Study | Year | Study design | Eligibility criteria | Sample size | Interventions |
| |||||
Alimohamadi et al. [11]. | 2013 | Randomized (double-blind) |
Vaginal bleeding and uterine cramps before the 20th week of pregnancy, live singleton by ultrasound | 71 71 |
Vaginal progesterone: 200 mg, twice a day for 1 week Control: placebo using the same method |
| |||||
Czajkowski et al. [19]. | 2007 | Randomized (double-blind) |
Vaginal bleeding usually accompanied by abdominal pain before 12 weeks of pregnancy, live singleton by ultrasound | 29 24 |
Vaginal progesterone: micronized, 300 mg, once per day for 6 weeksa Oral dydrogesterone: 30 mg using the same method |
| |||||
El-Zibdeh and Yousef [12]. | 2009 | Quasi-randomized (open-label) |
Mild or moderate vaginal bleeding during the first trimester of pregnancy, live embryo by ultrasound | 86 60 |
Oral dydrogesterone: 10 mg, twice per day until 1 week after bleeding had stopped Control: conservative treatment |
| |||||
Gerhard et al. [13]. | 1987 | Randomized (double-blind) | Vaginal bleeding during the first trimester of pregnancy, live singleton by ultrasound | 17 17 |
Vaginal progesterone: 25 mg, twice per day for 14 days after bleeding had stopped Control: placebo using the same method |
| |||||
Hui et al. [20].b | 2015 | Randomized | Vaginal bleeding between weeks 6 and 10 of pregnancy | 41 42 |
Vaginal progesterone: micronized Oral dydrogesterone |
| |||||
Omar et al. [14]. | 2005 | Randomized (open-label) | Mild or moderate vaginal bleeding before 13 weeks of pregnancy, live embryo by ultrasound | 74 80 |
Oral dydrogesterone: initial: 40 mg; maintenance: 10 mg, twice per day until bleeding had stopped or for 1 weekc Control: conservative treatment |
| |||||
Pandian [15]. | 2009 | Randomized (open-label) | Vaginal bleeding up to the 16th week of pregnancy, live embryo by ultrasound | 96 95 |
Oral dydrogesterone: initial: 40 mg; maintenance: 10 mg, twice per day until the 16th week of pregnancy Control: conservative treatment |
| |||||
Palagiano et al. [16]. | 2004 | Randomized (double-blind) |
Vaginal bleeding and uterine cramps between weeks 6 and 12 of pregnancy with a previous diagnosis of inadequate luteal phase, live embryo by ultrasound | 25 25 |
Vaginal progesterone: micronized, 90 mg, once per day for 5 daysd Control: placebo using the same method |
| |||||
Yassaee et al. [17]. | 2014 | Randomized (single-blind) |
Vaginal bleeding until the 20th week of pregnancy, live singleton by ultrasound | 30 30 |
Vaginal progesterone: micronized, 400 mg, once per day until bleeding stopped within less than 1 week Control: conservative treatmente |
aAdamed Inc., Poland; blimited information was available because the study was published only in abstract form; cunclear data regarding the duration of treatment; dCrinone 8%® (progesterone gel, Merck Serono Inc., Germany); eCyclogest® (Actavis Inc., UK).